About the journal
Качественная клиническая практика is an open-access journal published by Izdatelstvo OKI in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Izdatelstvo OKI
- ISSN
- 2588-0519 · 2618-8473
- Country
- Russia
- Languages
- russian
- Access
- Open access
- Articles in DOAJ
- 619
- Declared review time
- 8 weeks
- Declared peer-review model
- double_blind
- Official website
- https://www.clinvest.ru/jour/index
Index listings
- DOAJ · 2020-07-14
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
619
Most recent article
3 years ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
248
Last recorded publication year
2025
h-index
7
i10-index
3
From OpenAlex open data (CC0).
Editorial & policy8
- Last DOAJ review date
- 2024-09-16
- Added to DOAJ
- 2020-07-14
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 95%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Good clinical practice
- Source type
- journal
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Healthcare Systems and Public Health
- Healthcare Systems and Public Health
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Long-Term Effects of COVID-19
- Long-Term Effects of COVID-19
Show all subjects (50)
- SARS-CoV-2 and COVID-19 Research
- Pharmacovigilance and Adverse Drug Reactions
- SARS-CoV-2 and COVID-19 Research
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Neurological Disorders and Treatments
- Neurological Disorders and Treatments
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Pharmaceutical studies and practices
- Diabetes Management and Research
- Diabetes Management and Research
- Pharmaceutical studies and practices
- Drug-Induced Hepatotoxicity and Protection
- Statistical Methods in Clinical Trials
- Diabetes Treatment and Management
- Ethics in Clinical Research
- Drug-Induced Hepatotoxicity and Protection
- Statistical Methods in Clinical Trials
- Ethics in Clinical Research
- Diabetes Treatment and Management
- Asthma and respiratory diseases
- Artificial Intelligence in Healthcare and Education
- Venous Thromboembolism Diagnosis and Management
- Asthma and respiratory diseases
- Artificial Intelligence in Healthcare and Education
- Venous Thromboembolism Diagnosis and Management
- Chronic Lymphocytic Leukemia Research
- Pneumonia and Respiratory Infections
- Chronic Lymphocytic Leukemia Research
- Pneumonia and Respiratory Infections
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords (DOAJ)
- clinical trials
- pharmacoeconomics
- pharmacoepidemiology
- health technology assessment
- pharmacovigilance
- non-interventional studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ